Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
In the ongoing battle against cancer, understanding the precise molecular mechanisms of therapeutic agents is crucial for optimizing their application and developing next-generation treatments. Exatecan Mesylate Hydrate (CAS 197720-53-9) is a prime example of such a compound, playing a significant role as a pharmaceutical intermediate in the development of advanced anticancer therapies. Its efficacy stems from its potent inhibition of DNA topoisomerase I (TOP1), an enzyme essential for DNA metabolism.
DNA topoisomerase I is responsible for relieving torsional stress in the DNA helix during critical cellular processes like DNA replication and transcription. It achieves this by introducing transient single-strand breaks in the DNA, allowing it to unwind, and then resealing the break. Exatecan Mesylate Hydrate functions by binding to the transient complex formed between TOP1 and DNA, known as the cleavable complex. This binding stabilizes the complex, preventing the resealing of the DNA strand. As a result, when the cellular machinery for DNA replication encounters these stabilized complexes, the single-strand breaks are converted into permanent double-strand breaks.
These double-strand breaks trigger a cascade of cellular events, including cell cycle arrest and ultimately programmed cell death, or apoptosis. The potency of Exatecan Mesylate Hydrate in inducing these DNA damages is significantly higher than many other topoisomerase I inhibitors. This heightened efficacy is attributed to its unique chemical structure and its ability to form more stable complexes with TOP1 and DNA. For pharmaceutical manufacturers, this means a highly effective active pharmaceutical ingredient (API) intermediate that can lead to more potent anticancer drugs.
The application of Exatecan Mesylate Hydrate extends beyond its direct use as an intermediate. It is a key payload component in Antibody-Drug Conjugates (ADCs), where its cytotoxic properties are harnessed for targeted delivery. Its superior membrane permeability also allows for a bystander effect, enhancing its therapeutic impact in heterogeneous tumors. Researchers and companies seeking to buy Exatecan Mesylate Hydrate will find it to be a cornerstone compound for advancing cancer treatment strategies, with reliable suppliers offering high-purity material essential for reproducible research and development.
Understanding the detailed mechanism of action of Exatecan Mesylate Hydrate—from its interaction with topoisomerase I to its role in inducing DNA damage and apoptosis—is vital for unlocking its full therapeutic potential. As a trusted supplier, we are committed to providing researchers and manufacturers with the high-quality Exatecan Mesylate Hydrate necessary to drive innovation in cancer therapy.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
